News and Events
Cathy McCarty was the Principal Investigator for the Marshfield Clinic Personalized Medicine Research Project, with more than twenty genetic epidemiology and pharmacogenetic studies of metformin, coumadin and ACE inhibitors. She is currently collaborating with Dr.
A College of Pharmacy internal grant has been awarded to the project, "Enhance Comprehensive Pharmacist Services to Improve Patient Health: Creating a 21 st Century Precision Medicine Intensive Care Unit (ICU)."
The focus of the project is on sedation in mechanically ventilated patients and it aims to identify actionable genetic variants in ICU patients and evaluate the relationship between genotypes and drug efficacy as well as adverse drug reactions (ADR) in a real-world setting at the bedside.
Dr. Zhang is an Assistant Professor in the Department of Pharmaceutical Care & Health System (PCHS) and the Institute for Health Informatics (IHI). He is also a faculty member in Data Science graduate program. Dr. Zhang has extensive education background and research experience in the field of health and biomedical informatics, especially biomedical natural language processing and text mining.
Dr. R. Stephanie Huang, PhD, joined the the Department of Experimental and Clinical Pharmacology in the College of Pharmacy as a tenured associate professor in pharmacogenomics and is the newest member of the Institue of Personalized Medicine.
A Precison Medicine themed issue of Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy was published Sept. 20th, 2017. The issue was edited by Jeffrey R. Bishop an Vicki L. Ellingrod. Read the issue
The All of Us Research Program has begun enrolling its first participants as beta testers of the All of Us Research Program. Read more about this major milestone and their progress to date.
Zachary T. Rivers is pursuing a PhD in Social and Administrative Pharmacy at the University of Minnesota College of Pharmacy, where he previously earned his PharmD. His current research interests include economic evaluations of personalized/precision medicine, and integration of personalized/precision medicine into clinical practice.
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Conference on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.